Trade TPST anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Tempest Therapeutics, Inc. (TPST) is trading at US$1.08, up 0.00% today as of Aug 27, 16:00 EDT. The company has a market capitalisation of US$16.62M. Over the past 52 weeks, TPST has traded between US$0.84 and US$12.23. On Syfe you can trade TPST with $0 commission and add it to your watchlist.
| Previous close | US$1.08 |
|---|---|
| Market cap | US$16.62M |
| 52-week range | US$0.84 – US$12.23 |
| Volume | 68.98K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. Tempest Therapeutics was founded in 2011 and is headquartered in Brisbane, CA.
Year: 2021
Rani Therapeutics Names Nicholas Maestas CFO
Jun 29, 12:55 PM · MT Newswires
Tempest Therapeutics Registers 2.43 Million Shares for Resale
Jun 26, 8:47 PM · MT Newswires
Tempest Therapeutics CFO Nicholas Maestas Resigns
Jun 5, 10:05 AM · MT Newswires
Tempest Therapeutics Insider Bought Shares Worth $500,001, According to a Recent SEC Filing
Mar 25, 9:38 PM · MT Newswires
Tempest Therapeutics, Inc. (TPST) stock is trading at US$1.08, 0.00% from the previous close of US$1.08.
The market cap for Tempest Therapeutics, Inc. (TPST) stock is approximately US$16.62M.
The 52-week high for Tempest Therapeutics, Inc. (TPST) stock is US$12.23.
The 52-week low for Tempest Therapeutics, Inc. (TPST) stock is US$0.84.
Tempest Therapeutics, Inc. (TPST) does not currently pay a dividend.
Stay on top of TPST
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
